Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

Shares of MRNA have been declining after it lowered its long-term financial guidance. It has also pushed its breakeven point ...

We recently compiled a list of the 10 Most Promising Biotech Stocks According to Hedge Funds. In this article, we are going ...

A British drugmaker, GlaxoSmithKline (GSK), has sued American pharmaceutical company Moderna claiming it violated patent ...

GlaxoSmithKline is suing Moderna for allegedly using technology patented by GSK in its COVID-19 vaccine. Why it matters: It's ...

Eoneren/E+ via Getty Images Short interest for healthcare stocks in S&P 500 increased during September end vs.

Moderna Inc.’s shots for Covid-19 and respiratory syncytial virus infringe as many as seven GSK Plc patents related to mRNA ...

The Mandl team was originally employed by Novartis, but GSK acquired rights to their work and intellectual property when it acquired Novartis' global vaccine business in 2015. Only by tapping into ...

British drugmaker GlaxoSmithKline sued Moderna in US federal court in Delaware on Tuesday (Oct 15), accusing it of violating GSK patent rights in messenger RNA technology with its blockbuster Covid-19 ...

A Moderna spokesperson said the company was aware of the new litigation and would defend itself against the claims ...

周一，Jefferies维持对Moderna (NASDAQ: ...

英国制药公司葛兰素史克（GlaxoSmithKline）在特拉华州的一家联邦法院对美国Moderna公司提起诉讼。GSK声称Moderna在开发和销售其COVID-19疫苗Spikevax的过程中侵犯了GSK与信使RNA（mRNA）技术相关的专利。 该诉讼声称，Moderna用于将mRNA传递到细胞中的脂质纳米粒子侵犯了GSK的专利。根据GSK的说法，这些专利是Moderna疫苗产品所使用的mRN ...